Skip to content
Current diagnostic strategies for chlamydia and gonorrhoea in remote settings are not ideal due to extended delays in receiving laboratory results and the consequent delay in commencing treatment. Such delays can lead to increased infection rates in remote communities. One approach to address this problem is to use rapid point-of-care tests, which can provide clinical services with an immediate laboratory result, thus allowing treatment and the partner notification process to begin without delay.
It is therefore the aim of the Test, treat and go (TTANGO) trial to measure the effectiveness, cost-effectiveness and acceptability of rapid point-of-care testing for chlamydia and gonorrhoea infections in remote Aboriginal communities. The project will involve health services in Queensland and Western Australia. In the first year, half of the health services will be randomly assigned to manage the infections under current guidelines, and the other services will supplement standard guidelines with rapid point-of-care testing. In the second year, the clinics will switch to the other management approach.
The results from this research project will help to guide sexual health clinical practice in remote Aboriginal communities. If successful, point-of-care tests will benefit remote Aboriginal communities by reducing the prevalence of chlamydia and gonorrohea, and the associated harmful impacts.
Co-ordinator, TTANGO Trial
Ph: (03) 9282 2136